CBL (gene): Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 45: | Line 45: | ||
[[Category:Signal transduction]] | [[Category:Signal transduction]] | ||
[[Category:Ubiquitin-protein ligases]] | [[Category:Ubiquitin-protein ligases]] | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 05:42, 17 March 2025
CBL (Casitas B-lineage Lymphoma) is a gene that encodes a member of the Cbl family of E3 ubiquitin-protein ligases. CBL proteins play a crucial role in cell signaling and cancer development.
Function[edit]
The CBL gene is involved in the intracellular signaling pathways of many cell surface receptors involved with cellular growth, differentiation, and apoptosis. These receptors include EGFR, PDGFR, and c-Met. The protein encoded by the CBL gene functions as a negative regulator of many signaling pathways that start from these cell surface receptors.
Clinical significance[edit]
Mutations in the CBL gene have been associated with Noonan syndrome and myeloproliferative disorder, both of which are conditions that affect multiple systems of the body.
Structure[edit]
The CBL protein has a modular structure consisting of an N-terminal tyrosine kinase binding (TKB) domain, a linker region, a RING finger domain, a proline-rich region, and a C-terminal ubiquitin-associated (UBA) domain.
Interactions[edit]
CBL has been shown to interact with:
See also[edit]
References[edit]
<references />
External links[edit]
| Genes on human chromosome 11 | ||||
|---|---|---|---|---|
This human genetics related article is a stub.
|
| Tyrosine kinase inhibitors | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This tyrosine kinase inhibitor related article is a stub.
|
| Ubiquitin-protein ligases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This Ubiquitin-protein ligases related article is a stub.
|
